CXM Stock Overview Provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Chemed Corporation Competitors Price History & Performance
Summary of share price highs, lows and changes for Chemed Historical stock prices Current Share Price US$500.00 52 Week High US$605.00 52 Week Low US$476.00 Beta 0.46 1 Month Change -6.54% 3 Month Change -4.76% 1 Year Change -4.76% 3 Year Change 8.70% 5 Year Change 27.55% Change since IPO 2,497.40%
Recent News & Updates
Chemed Corporation Declares Quarterly Dividend, Payable on December 6, 2024 Nov 08
Third quarter 2024 earnings released: EPS: US$5.04 (vs US$4.97 in 3Q 2023) Oct 30
Chemed Corporation Revises Consolidated Earnings Guidance for the Full Year 2024 Oct 30
CEO, President & Director recently sold €1.1m worth of stock Sep 29
Chemed Corporation to Report Q3, 2024 Results on Oct 29, 2024 Sep 14
Executive Vice President recently sold €883k worth of stock Sep 11 See more updates
Chemed Corporation Declares Quarterly Dividend, Payable on December 6, 2024 Nov 08
Third quarter 2024 earnings released: EPS: US$5.04 (vs US$4.97 in 3Q 2023) Oct 30
Chemed Corporation Revises Consolidated Earnings Guidance for the Full Year 2024 Oct 30
CEO, President & Director recently sold €1.1m worth of stock Sep 29
Chemed Corporation to Report Q3, 2024 Results on Oct 29, 2024 Sep 14
Executive Vice President recently sold €883k worth of stock Sep 11
Chemed Corporation Declares Quarterly Dividend, Payable on August 30, 2024 Aug 03
Executive Vice President recently sold €1.0m worth of stock Aug 02
Second quarter 2024 earnings released: EPS: US$4.70 (vs US$3.55 in 2Q 2023) Jul 25
Chemed Corporation to Report Q2, 2024 Results on Jul 24, 2024 Jul 02
CEO, President & Director recently sold €750k worth of stock Jun 10
First quarter dividend of US$0.40 announced May 27
Chemed Corporation Declares Quarterly Dividend, Payable on June 18, 2024 May 22
CEO, President & Director recently sold €2.1m worth of stock May 19
Chemed Corporation Reiterates Earnings Guidance for Full Year 2024 Apr 26
First quarter 2024 earnings released: EPS: US$4.30 (vs US$3.62 in 1Q 2023) Apr 25
Chemed Corporation, Annual General Meeting, May 20, 2024 Apr 09
New major risk - Revenue and earnings growth Apr 08
Chemed Corporation to Report Q1, 2024 Results on Apr 24, 2024 Apr 02
Executive Vice President recently sold €1.2m worth of stock Apr 02
Now 22% overvalued after recent price rise Mar 05
Full year 2023 earnings released: EPS: US$18.11 (vs US$16.72 in FY 2022) Feb 28
Chemed Corporation Declares Quarterly Dividend, Payable on March 15, 2024 Feb 17
Chemed Corporation to Report Q4, 2023 Results on Feb 27, 2024 Feb 15
Chemed Corporation Appoints Michael D. Witzeman as Chief Financial Officer, Effective January 1, 2024 Dec 19
CEO, President & Director recently sold €800k worth of stock Dec 15
Executive Vice President recently sold €530k worth of stock Nov 28
Chemed Corporation Announces the Retirement of David P. Williams as Chief Financial Officer Effective December 31, 2023 Nov 05 Chemed Corporation Announces the Retirement of David P. Williams as Chief Financial Officer Effective December 31, 2023
CEO, President & Director recently sold €1.6m worth of stock Nov 02
Chemed Corporation Provides Earnings Guidance for the Full-Year 2023 Oct 28
Third quarter 2023 earnings released: EPS: US$4.97 (vs US$3.82 in 3Q 2022) Oct 26
Chemed Corporation to Report Q3, 2023 Results on Oct 25, 2023 Oct 12
CEO, President & Director recently sold €1.9m worth of stock Aug 08
Second quarter 2023 earnings released: EPS: US$3.55 (vs US$4.45 in 2Q 2022) Jul 27
Chemed Corporation to Report Q2, 2023 Results on Jul 26, 2023 Jul 13
Independent Director recently sold €149k worth of stock May 31
CEO, President & Director recently sold €2.0m worth of stock May 09
First quarter 2023 earnings released: EPS: US$3.62 (vs US$4.28 in 1Q 2022) Apr 28
Executive VP & CFO recently sold €2.0m worth of stock Mar 22
CEO, President & Director recently sold €959k worth of stock Mar 12
Full year 2022 earnings released: EPS: US$16.72 (vs US$17.14 in FY 2021) Feb 24
Chemed Corporation Declares Quarterly Cash Dividend Payable on March 17, 2023 Feb 18
Chemed Corporation to Report Q4, 2022 Results on Feb 23, 2023 Feb 10
CEO, President & Director recently sold €987k worth of stock Nov 23
Executive VP & CFO recently sold €3.9m worth of stock Nov 16
CEO, President & Director recently sold €990k worth of stock Nov 05
Chemed Corporation Declares Quarterly Cash Dividend on the Capital Stock, Payable on December 5, 2022 Nov 05
Third quarter 2022 earnings released: EPS: US$3.82 (vs US$4.62 in 3Q 2021) Nov 02
Chemed Corporation Provides Earnings Guidance for the Year 2022 Nov 01
Chemed Corporation to Report Q3, 2022 Results on Oct 31, 2022 Oct 18
CEO, President & Director recently sold €948k worth of stock Sep 15
CEO, President & Director recently sold €1.4m worth of stock Aug 23 Chemed Corporation Declares Quarterly Cash Dividend on the Capital Stock, Payable on September 2, 2022
Chemed Corporation Provides Earnings Guidance for the Year 2022 Jul 29
Second quarter 2022 earnings released: EPS: US$4.45 (vs US$3.57 in 2Q 2021) Jul 28
Chemed Corporation to Report Q2, 2022 Results on Jul 27, 2022 Jul 07
Independent Director recently sold €116k worth of stock Jun 14
Chemed Corporation Declares Quarterly Cash Dividend, Payable on June 15, 2022 May 17
CEO, President & Director recently sold €1.4m worth of stock May 05
First quarter 2022 earnings released: EPS: US$4.28 (vs US$4.09 in 1Q 2021) Apr 28
Independent Director recently sold €194k worth of stock Apr 15
Chemed Corporation, Annual General Meeting, May 16, 2022 Apr 09
Chemed Corporation to Report Q1, 2022 Results on Apr 26, 2022 Apr 08
Executive Vice President recently sold €473k worth of stock Mar 09
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 26
Chemed Corporation Declares Quarterly Dividend, Payable on March 18, 2022 Feb 19
Chemed Corporation to Report Q4, 2021 Results on Feb 24, 2022 Feb 08
Independent Director recently sold €235k worth of stock Dec 30
CEO, President & Director recently sold €1.3m worth of stock Nov 17
Executive Vice President recently sold €845k worth of stock Nov 03
Third quarter 2021 earnings released: EPS US$4.62 (vs US$4.25 in 3Q 2020) Oct 29
CEO, President & Director recently sold €1.2m worth of stock Aug 11
Second quarter 2021 earnings released: EPS US$3.57 (vs US$5.16 in 2Q 2020) Jul 28
Independent Director recently sold €326k worth of stock Jun 22
CEO, President & Director recently sold €1.2m worth of stock Jun 08
Chemed Corporation Declares Quarterly Dividend, Payable on June 16, 2021 May 18
Independent Chairman recently sold €249k worth of stock May 06
First quarter 2021 earnings released: EPS US$4.09 (vs US$3.50 in 1Q 2020) Apr 29
New 90-day low: €362 Feb 27
Full year 2020 earnings released: EPS US$20.02 (vs US$13.77 in FY 2019) Feb 25
Revenue misses expectations Feb 25
Chemed Corporation to Report Q4, 2020 Results on Feb 23, 2021 Feb 04
New 90-day high: €444 Jan 26
New 90-day high: €442 Jan 09
CEO, President & Director recently sold €1.1m worth of stock Dec 31
VP & Controller recently sold €1.1m worth of stock Dec 19
New 90-day low: €380 Dec 05
New 90-day low: €394 Nov 11
Executive Vice President recently sold €923k worth of stock Nov 07
Revenue beats expectations Nov 07
Third quarter 2020 earnings released: EPS US$4.25 Nov 07
Third-quarter earnings released: Revenue beats expectations Oct 30
Third quarter earnings released Oct 30
Chemed Corporation to Report Q3, 2020 Results on Oct 29, 2020 Oct 13
Executive Vice President recently sold €894.5k worth of stock Sep 17
New 90-day high - €444 Sep 03 Shareholder Returns CXM DE Healthcare DE Market 7D -3.8% -3.7% -2.0% 1Y -4.8% 15.8% 6.8%
See full shareholder returns
Return vs Market: CXM underperformed the German Market which returned 6.9% over the past year.
Price Volatility Is CXM's price volatile compared to industry and market? CXM volatility CXM Average Weekly Movement 4.8% Healthcare Industry Average Movement 4.7% Market Average Movement 4.9% 10% most volatile stocks in DE Market 11.4% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: CXM has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: CXM's weekly volatility (5%) has been stable over the past year.
About the Company Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Show more Chemed Corporation Fundamentals Summary How do Chemed's earnings and revenue compare to its market cap? CXM fundamental statistics Market cap €7.50b Earnings (TTM ) €289.94m Revenue (TTM ) €2.28b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) CXM income statement (TTM ) Revenue US$2.38b Cost of Revenue US$1.53b Gross Profit US$847.80m Other Expenses US$546.06m Earnings US$301.73m
Dividends
0.4% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/23 20:19 End of Day Share Price 2024/12/23 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Chemed Corporation is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Ishan Majumdar Baptista Research Adam Feinstein Barclays Joanna Sylvia Gajuk BofA Global Research
Show 9 more analysts 
